Daniel Yannicelli

608 total citations
13 papers, 367 citations indexed

About

Daniel Yannicelli is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Oncology. According to data from OpenAlex, Daniel Yannicelli has authored 13 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Internal Medicine and 2 papers in Oncology. Recurrent topics in Daniel Yannicelli's work include Atrial Fibrillation Management and Outcomes (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Cardiac Arrhythmias and Treatments (3 papers). Daniel Yannicelli is often cited by papers focused on Atrial Fibrillation Management and Outcomes (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Cardiac Arrhythmias and Treatments (3 papers). Daniel Yannicelli collaborates with scholars based in United States, Canada and Belgium. Daniel Yannicelli's co-authors include Winnie W. Nelson, Keith R. McCrae, Jeff Schein, Concetta Crivera, Dejan Milentijevic, Patrick Lefèbvre, Jonathan Fortier, François Laliberté, Alok A. Khorana and Žhong Yuan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The American Journal of Cardiology.

In The Last Decade

Daniel Yannicelli

13 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Yannicelli United States	7	304	281	81	54	33	13	367
S. Haas Germany	9	148 0.5×	227 0.8×	31 0.4×	93 1.7×	8 0.2×	22	294
T. Poli Italy	6	198 0.7×	244 0.9×	43 0.5×	96 1.8×	9 0.3×	10	283
Sandra Marten Germany	8	342 1.1×	263 0.9×	7 0.1×	52 1.0×	23 0.7×	24	425
L M Tsai Taiwan	7	257 0.8×	92 0.3×	24 0.3×	38 0.7×	16 0.5×	8	325
M. Behan United Kingdom	8	169 0.6×	90 0.3×	79 1.0×	140 2.6×	24 0.7×	13	345
Erik Wellander Sweden	6	162 0.5×	178 0.6×	62 0.8×	130 2.4×	10 0.3×	7	302
Anna Kaczyńska Poland	6	248 0.8×	263 0.9×	9 0.1×	21 0.4×	58 1.8×	17	325
Alexander G.G. Turpie Canada	8	298 1.0×	137 0.5×	4 0.0×	36 0.7×	49 1.5×	13	343
Shamik Aikat United States	9	231 0.8×	40 0.1×	29 0.4×	45 0.8×	35 1.1×	14	303
J. Cairns Canada	9	358 1.2×	40 0.1×	8 0.1×	56 1.0×	22 0.7×	14	440

Countries citing papers authored by Daniel Yannicelli

Since Specialization

Citations

This map shows the geographic impact of Daniel Yannicelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Yannicelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Yannicelli more than expected).

Fields of papers citing papers by Daniel Yannicelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Yannicelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Yannicelli. The network helps show where Daniel Yannicelli may publish in the future.

Co-authorship network of co-authors of Daniel Yannicelli

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Yannicelli. A scholar is included among the top collaborators of Daniel Yannicelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Yannicelli. Daniel Yannicelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Walker, Scott E., et al.. (2018). Stability of meropenem in saline and dextrose solutions and compatibility with potassium chloride. The Canadian Journal of Hospital Pharmacy. 51(4). 5 indexed citations

Streiff, Michael B., Dejan Milentijevic, Keith R. McCrae, et al.. (2018). Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer. American Journal of Hematology. 93(5). 664–671. 68 indexed citations

Yuan, Žhong, Erica A. Voss, Frank DeFalco, et al.. (2017). Risk Prediction for Ischemic Stroke and Transient Ischemic Attack in Patients Without Atrial Fibrillation: A Retrospective Cohort Study. Journal of Stroke and Cerebrovascular Diseases. 26(8). 1721–1731. 8 indexed citations

Khorana, Alok A., Keith R. McCrae, Dejan Milentijevic, et al.. (2017). Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis. Research and Practice in Thrombosis and Haemostasis. 1(1). 14–22. 109 indexed citations

Khorana, Alok A., Keith R. McCrae, Dejan Milentijevic, et al.. (2016). Duration of anticoagulant therapy and VTE recurrence in patients with cancer.. Journal of Clinical Oncology. 34(15_suppl). 10112–10112. 4 indexed citations

Streiff, Michael B., Dejan Milentijevic, Keith R. McCrae, et al.. (2016). Recurrent VTE in cancer patients treated with anticoagulation.. Journal of Clinical Oncology. 34(15_suppl). 10024–10024. 3 indexed citations

Streiff, Michael B., Dejan Milentijevic, Keith R. McCrae, et al.. (2016). Safety of Anticoagulant Therapies for Treatment of Venous Thromboembolism in Patients with Cancer. Blood. 128(22). 1178–1178. 3 indexed citations

Peacock, W. Frank, Manesh R. Patel, Nicholas Sicignano, et al.. (2015). Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban. Clinical Cardiology. 38(2). 63–68. 127 indexed citations

Khorana, Alok A., Daniel Yannicelli, Keith R. McCrae, et al.. (2015). Abstract 210: Evaluation of US Prescription Patterns: Are Treatment Guidelines For Cancer-associated Venous Thromboembolism (VTE) Followed?. Circulation Cardiovascular Quality and Outcomes. 8(suppl_2). 3 indexed citations

10.

Yuan, Žhong, Rupa Makadia, Patrick Ryan, et al.. (2015). Incidence of ischemic stroke or transient ischemic attack in patients with multiple risk factors with or without atrial fibrillation: a retrospective cohort study. Current Medical Research and Opinion. 31(7). 1257–1266. 7 indexed citations

11.

Khorana, Alok A., Keith R. McCrae, Dejan Milentijevic, et al.. (2015). Current Practice Patterns and Patient Persistence on Anticoagulant Treatments for Cancer-Associated Thrombosis. Blood. 126(23). 626–626. 15 indexed citations

12.

Hopf, K, Larry E. Fields, Troy C. Sarich, et al.. (2014). 40 Detection and Evaluation of Major Bleeding in Atrial Fibrillation or Total Hip or Knee Replacement Patients Treated with Rivaroxaban. Annals of Emergency Medicine. 64(4). S15–S15. 1 indexed citations

13.

Kowey, Peter R., Daniel Yannicelli, & Ezra A. Amsterdam. (2004). Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting. The American Journal of Cardiology. 94(5). 663–665. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact